Pristinamycin
- Generic Name
- Pristinamycin
- Drug Type
- Small Molecule
- CAS Number
- 270076-60-3
- Unique Ingredient Identifier
- 4O8O7Q7IU4
Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia
Phase 4
Terminated
- Conditions
- Pneumonia
- Interventions
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2023-05-08
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 161
- Registration Number
- NCT02332577
- Locations
- 🇫🇷
Investigational Site Number :250010, Grenoble, France
🇫🇷Investigational Site Number :250029, Avoine, France
🇫🇷Investigational Site Number :250015, COLOMBES Cedex, France
Efficacy Study of Pristinamycin Versus Amoxicillin to Treat Tonsillitis Induced by Streptococcus in Children
- First Posted Date
- 2006-10-29
- Last Posted Date
- 2009-03-17
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 395
- Registration Number
- NCT00393744
- Locations
- 🇫🇷
Sanofi-Aventis, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath